Inici › Càncer de bufeta › Maryland › Baltimore
Assaigs clínics de Càncer de bufeta a Baltimore, MD
24 estudis de Càncer de bufeta busquen participants en centres de Baltimore i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
ReclutantFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- i 2 més
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutantFase 2
- Johns Hopkins University, Baltimore
DK222 Study at Hopkins
ReclutantFase 1
- Johns Hopkins Hospital, Baltimore
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
ReclutantFase 1/2
- Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Johns Hopkins Hospital, Baltimore
- i 2 més
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
ReclutantFase 3
- Johns Hopkins University ( Site 0843), Baltimore
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutantFase 3
- Johns Hopkins Hospital, Baltimore
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
ReclutantFase 2
- Anne Arundel Urology, Annapolis · a 22 mi
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutantFase 1
- Johns Hopkins Kimmel Cancer Center, Baltimore
Measuring Surgical Recovery After Radical Cystectomy
ReclutantEstudi observacional
- John Hopkins Medical Institutions, Baltimore
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
ReclutantFase 1/2
- John Hopkins Hospital, Baltimore
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
ReclutantFase 2/3
- Johns Hopkins Hospital, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutantFase 2
- The John Hopkins Hospital, Baltimore
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
ReclutantFase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Bladder EpiCheck Product Development Study
ReclutantEstudi observacional
- Chesapeake Urology Research Associates, Towson · a 8 mi
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutantFase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Renal Retention in High Grade Upper Tract Urothelial Cancer
ReclutantFase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Image-Guided Gynecologic Brachytherapy
Reclutant
- The SKCCC at Johns Hopkins, Baltimore
Blue Light Cystoscopy With Cysview® Registry
ReclutantEstudi observacional
- Johns Hopkins Medicine, Baltimore
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Reclutant
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Hospital, Baltimore
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
ReclutantFase 3
- Johns Hopkins University School of Medicine, Baltimore
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Reclutant
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · a 8 mi
Gender Related Coping and Survivorship for Genitourinary Cancers
ReclutantEstudi observacional
- Johns Hopkins Hospital, Baltimore
Assaigs de Càncer de bufeta en altres ciutats
- New York City, NY35 estudis
- Nashville, TN31 estudis
- Houston, TX31 estudis
- Dallas, TX27 estudis
- Boston, MA26 estudis
- Washington, DC26 estudis
- Los Angeles, CA24 estudis
- St. Louis, MO22 estudis
- Philadelphia, PA21 estudis
- Seattle, WA21 estudis
- Edison, NJ21 estudis
- Chicago, IL21 estudis
Altres estudis a Baltimore
- Càncer de pulmó de cèl·lules no petites60 estudis
- Càncer de mama47 estudis
- Càncer de pròstata43 estudis
- Càncer de pulmó40 estudis
- Càncer (tots els tipus)37 estudis
- Càncer colorrectal31 estudis
- Càncer de pàncrees31 estudis
- Càncer metastàtic28 estudis
- Obesitat25 estudis
- Insuficiència cardíaca24 estudis
- Ictus22 estudis
- Càncer d'ovari22 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.